Neurostimulation Devices Market Size, Analysis Report 2032

Neurostimulation Devices Market Size - By Product (Deep Brain, Gastric Electric, Spinal Cord, Sacral Nerve, Vagus Nerve Stimulator), By Application (Epilepsy, Pain Management, Essential Tremor, Urinary & Fecal Incontinence) & Forecast, 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global neurostimulation devices market 3600&nbsp;synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Regional trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

Chapter 3&nbsp;&nbsp;&nbsp;Neurostimulation Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Increasing demand for minimally invasive surgery in developed countries

3.5.1.2&nbsp;&nbsp;&nbsp;Increasing prevalence of neurological disorders

3.5.1.3&nbsp;&nbsp;&nbsp;Technological advancements in neurostimulation devices

3.5.1.4&nbsp;&nbsp;&nbsp;Increasing number of elderly patients with neurological disorders

3.5.1.5&nbsp;&nbsp;&nbsp;Investments by companies and organizations across the globe

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;Complications associated with neurostimulation devices

3.5.2.2&nbsp;&nbsp;&nbsp;Lack of skilled healthcare practitioners

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By product

3.6.2&nbsp;&nbsp;&nbsp; By application

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Neurostimulation Devices Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Deep brain stimulator

5.3&nbsp;&nbsp;&nbsp; Gastric electric stimulator

5.4&nbsp;&nbsp;&nbsp; Spinal cord stimulator

5.5&nbsp;&nbsp;&nbsp; Sacral nerve stimulator

5.6&nbsp;&nbsp;&nbsp; Vagus nerve stimulator

5.7&nbsp;&nbsp;&nbsp; Transcutaneous electrical nerve stimulation (TENS)

5.8&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Neurostimulation Devices Market Size and Forecast, By Application, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Pain management

6.3&nbsp;&nbsp;&nbsp; Epilepsy

6.4&nbsp;&nbsp;&nbsp; Essential tremor

6.5&nbsp;&nbsp;&nbsp; Urinary and fecal incontinence

6.6&nbsp;&nbsp;&nbsp; Depression

6.7&nbsp;&nbsp;&nbsp; Dystonia

6.8&nbsp;&nbsp;&nbsp; Gastroparesis

6.9&nbsp;&nbsp;&nbsp; Parkinson&#39;s disease

6.10&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Neurostimulation Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Italy

7.3.5&nbsp;&nbsp;&nbsp; Spain

7.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.2&nbsp;&nbsp;&nbsp; South Africa

7.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; Aleva Neurotherapeutics S.A

8.3&nbsp;&nbsp;&nbsp; BioControl Medical

8.4&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

8.5&nbsp;&nbsp;&nbsp; ElectroCore, Inc.

8.6&nbsp;&nbsp;&nbsp; Endostim

8.7&nbsp;&nbsp;&nbsp; Helbling Holding AG

8.8&nbsp;&nbsp;&nbsp; Innovative Health Solutions, Inc.

8.9&nbsp;&nbsp;&nbsp; Laborie, Inc.

8.10&nbsp;&nbsp;&nbsp; LivaNova PLC

8.11&nbsp;&nbsp;&nbsp; Medtronic plc

8.12&nbsp;&nbsp;&nbsp; MicroTransponder

8.13&nbsp;&nbsp;&nbsp; Neuronetics, Inc.

8.14&nbsp;&nbsp;&nbsp; Parasym Ltd.

8.15&nbsp;&nbsp;&nbsp; RS Medical

8.16&nbsp;&nbsp;&nbsp; Synapse Biomedical

8.17&nbsp;&nbsp;&nbsp; tVNS Technologies GmbH (Cerbomed)

&nbsp;&nbsp;&nbsp;

Neurostimulation Devices Market

Customize This Report

Industries

Information

Link

Global Headquarters